Full text is available at the source.
miR-125a-5p promotes normal angiogenesis in diabetic foot ulcers by targeting GSTM5
miR-125a-5p helps normal blood vessel growth in diabetic foot ulcers by affecting GSTM5
AI simplified
Abstract
Low expression of both miR-125a-5p and GSTM5 is associated with impaired angiogenesis in chronic diabetic foot ulcer patients.
- Distinct expression patterns of miR-125a-5p and GSTM5 were observed between acute and chronic diabetic foot ulcer patients.
- Low levels of miR-125a-5p and GSTM5 in chronic patients correlated positively with changes in angiogenic markers.
- Inhibition of miR-125a-5p and GSTM5 in endothelial cells in vitro resulted in reduced angiogenesis.
- MiR-125a-5p is suggested to promote normal angiogenesis in diabetic foot ulcers by targeting GSTM5.
AI simplified